| 1 |
34937801 | Accelerating Clinical Development of Idasanutlin through a Physiologically Based Pharmacokinetic Modeling Risk Assessment for CYP450 Isoenzyme-Related Drug-Drug Interactions. | 2022 Mar |
1 |
| 2 |
32472569 | Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus. | 2021 Feb |
1 |
| 3 |
33398386 | Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach. | 2021 Apr |
2 |
| 4 |
33677444 | Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life. | 2021 |
1 |
| 5 |
32514626 | Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma. | 2020 Jul |
1 |
| 6 |
29255993 | Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining. | 2018 Apr |
1 |
| 7 |
29368050 | Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors. | 2018 Mar |
1 |
| 8 |
29749631 | Persistence of a Posaconazole-Mediated Drug-Drug Interaction With Ranolazine After Cessation of Posaconazole Administration: Impact of Obesity and Implications for Patient Safety. | 2018 Nov |
1 |
| 9 |
29851709 | Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient Safety. | 2018 Aug |
1 |
| 10 |
29991575 | Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7. | 2018 Sep |
1 |
| 11 |
26864621 | Salvage Treatment of Mucormycosis Post-Liver Transplant With Posaconazole During Sirolimus Maintenance Immunosuppression. | 2017 Apr |
1 |
| 12 |
27545757 | Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib. | 2017 May |
1 |
| 13 |
28161120 | Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments. | 2017 Feb |
3 |
| 14 |
27125217 | Long QT Syndrome Leading to Multiple Cardiac Arrests After Posaconazole Administration in an Immune-Compromised Patient with Sepsis: An Unusual Case Report. | 2016 Apr 29 |
1 |
| 15 |
27530708 | Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole. | 2016 Oct |
5 |
| 16 |
26232156 | A clinical approach to solving discrepancies in therapeutic drug monitoring results for patients on sirolimus or tacrolimus: Towards personalized medicine, immunosuppression and pharmacogenomics. | 2015 Oct 23 |
1 |
| 17 |
28975914 | Posaconazole: An Update of Its Clinical Use. | 2015 Oct 21 |
2 |
| 18 |
22176629 | Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers. | 2012 Jan |
1 |
| 19 |
22564264 | Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. | 2012 Sep |
3 |
| 20 |
21126270 | Posaconazole: clinical pharmacokinetics and drug interactions. | 2011 Jan |
1 |
| 21 |
20840439 | Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview. | 2010 Oct |
1 |
| 22 |
19196220 | Effects of oral posaconazole on the pharmacokinetics of sirolimus. | 2009 Mar |
2 |
| 23 |
19302901 | Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers. | 2009 Feb |
3 |
| 24 |
19346885 | Posaconazole-increased vincristine neurotoxicity in a child: a case report. | 2009 Apr |
1 |
| 25 |
15066665 | Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. | 2004 Apr |
4 |
| 26 |
15311563 | Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. | 2004 Jun |
1 |